EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
EUPRAXIA PHARMACEUTICALS INC.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026
$6.95+0.33 (+4.98%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Eupraxia Pharmaceuticals statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $419.05M | $166.30M |
| Enterprise Value | $336.89M | $88.19M |
| PB Ratio | 5.11 | 2.03 |
| P/TBV Ratio | 5.11 | 2.29 |
Income (trailing twelve months)
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Revenue | $0 | $58.34M |
| Pretax Income | -$38.59M | -$14.34M |
| Net Income | -$38.58M | -$22.46M |
| EPS (Diluted) | -$1.03 | -$0.83 |
Returns
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -66.8% | -53.2% |
| Return on Assets (ROA) | -63.7% | -40.9% |
Balance sheet
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $80.56M | $61.43M |
| Net Cash (Debt) | $80.56M | $15.35M |
| Net Cash Per Share | $1.34 | $0.66 |
| Equity (Book Value) | $82.04M | $49.09M |
| Book Value Per Share | $1.36 | $1.37 |
| Tangible Book Value | $82.04M | $23.52M |
| Working Capital | $79.47M | $76.81M |
Financial position
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 15.12 | 3.34 |
| Quick Ratio | 14.44 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$28.55M | -$12.35M |
Efficiency
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
Dividends and yields
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -9.21% | -23.3% |
| Buyback Yield | -17.6% | -0.59% |
| Shareholder Yield | -17.6% | 0.00% |
Shares
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 60,294,800 | 58,127,000 |
| Shares Change (YoY) | 17.8% | 10.9% |
| Float | 54,451,600 | 49,136,700 |
| Shares Held by Insiders | 9.69% | 11.6% |
| Shares Held by Institutions | 41.1% | 59.4% |
Taxes
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Income Tax | $19.09K | $79.87K |
Scores
| Measure | Eupraxia Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | 42.43 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Eupraxia Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.